Cyclica is the partner of choice for data-driven drug discovery. We advance molecules that embrace the complexity of disease.
Our computational approach to polypharmacology is unique in the industry. We use a proteome-wide lens to evaluate multiple novel and rare on and off-target interactions simultaneously.
We’re also the only company of our kind that integrates science to advance molecules downstream. A structure-based view keeps our work accountable to biology, chemistry, physics, and genomics.
To learn more about Cyclica and how we partner, please visit www.cyclicarx.com
Cyclica. From molecule to medicine.
TechnologiesAI Companies (Drug Discovery)
Posts Mentioning This Company
Provide insight and analysis into a drugs' poylpharmacology via its AI-powered platform LignadExpress utilizing structure based drug discovery approach.
Rapidly screening ligands across the proteome
No pipelines published yet
No services posted yet